Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

A Peek Into The Markets: US Stock Futures Down; All Eyes On Jobs Report

Courtesy of Benzinga.

A Peek Into The Markets: US Stock Futures Down; All Eyes On Jobs Report

Pre-open movers

U.S. stock futures traded lower in early pre-market trade. Data on nonfarm payrolls and unemployment rate for June will be released at 8:30 a.m. ET.

Futures for the Dow Jones Industrial Average dropped 38 points to 26,932, while the Standard & Poor’s 500 index futures fell 5.3 points to 2,995.00. Futures for the Nasdaq 100 index declined 15.75 points to 7,871.75.

Oil prices traded mixed as Brent crude futures rose 0.5% to trade at $63.60 per barrel, while US WTI crude futures fell 0.8% to trade at $56.89 a barrel.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.4%, STOXX Europe 600 Index falling 0.4% and German DAX 30 index dropping 0.4%. The UK’s FTSE index was trading lower by 0.4%, while French CAC 40 Index slipped 0.3%.

In Asian markets, Japan’s Nikkei Stock Average rose 0.2%, Hong Kong’s Hang Seng Index slipped 0.07%, China’s Shanghai Composite Index rose 0.19% and India’s BSE Sensex fell 0.99%.

Broker Recommendation

Analysts at Raymond James downgraded Senseonics Holdings, Inc. (NYSE: SENS) from Outperform to Market Perform.

Senseonics shares fell 2.7 percent to $1.84 in pre-market trading.

Breaking News

Karyopharm Therapeutics Inc (NASDAQ: KPTI) announced FDA approval of XPOVIO for treatment of patients with relapsed, refractory multiple myeloma.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) disclosed that ULTOMIRIS has received marketing authorization from the European Commission for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria.

WPP PLC (NYSE: WPP) reported the acquisition of majority stake in Italian technology-driven creative agency, Aquest.

Grifols, S.A. (NASDAQ: GRFS) reported the FDA approval of Xembify, its new 20% subcutaneous immunoglobulin for treating primary immunodeficiencies.

Posted-In: A Peek Into The Markets US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!